Introduction
The term antimicrobial agent has been defined as 'a naturally occurring, semi-synthetic or synthetic substance that exhibits antimicrobial activity (kills or inhibits the growth of microorganisms) at concentrations attainable in vivo' (292) , and includes agents active against bacteria, protozoa, viruses and fungi. The most commonly used category of antimicrobial agent and the one currently of greatest public health interest is the antibacterial class and this overview will focus exclusively on the antibacterial subset of antimicrobial agents and will use the term antimicrobial in this narrower context. Furthermore, this review will focus only on selected terrestrial livestock species, especially cattle, pigs and poultry, which globally provide the top three sources of meat. Information on antimicrobial use in other species (especially buffalo, camels and goats) can sometimes be difficult to find and is often incomplete, although in the case of bees there is an excellent recent review (220) .
The use of antimicrobial agents in livestock continues to allow the growth of healthier and more productive animals, with lower incidence of disease, reduced morbidity and mortality, and the production of abundant quantities of nutritious, high-quality and low-cost food for human consumption (192) . Sixty years ago the use of antimicrobial agents was reviewed, with findings that would not be unexpected today (232, 233) . Penicillin (in the form of procaine and benzathine salts and penethemate) was used to treat various conditions, including bovine mastitis, pneumonia in calves, metritis in cows, and erysipelas in pigs. Streptomycin, especially the less toxic dihydrostreptomycin, was found to be useful for preserving bovine semen and treating bovine mastitis, leptospirosis, pneumonia, intrauterine infections and swine dysentery. Bacitracin was indicated for bovine infectious keratitis, mastitis and topical infections. Chlortetracycline and oxytetracycline were widely and successfully used for bovine pneumonia prophylaxis and treatment of calf and piglet scours, foot rot, metritis and acute mastitis, as well as Pasteurella multocida
Veterinary and human antimicrobial use
It will quickly become apparent that there are some significant differences between the use of antimicrobial agents in livestock and their use in humans. The most notable differences appear in intensive livestock production systems (that will later be classified as landless livestock production systems) where large populations of livestock are raised at a single site and often in the same airspace. Some important differences between veterinary and human antimicrobial uses are set out in Table I .
Global sales of antimicrobial products for use in livestock
It is helpful to gain an insight into the dimensions of potential antimicrobial use in livestock. While the number of animals treated and the dose regimen implemented provide more information about use (see below), an outline of sales is a useful starting point.
A report by Vetnosis (68) summarises the global animal health anti-infective market in all species. The antiinfective market includes products to treat bacterial and fungal diseases but does not include the medicinal feed additives. Thus, the anti-infective market includes infections in poultry. At this time erythromycin, the first of the macrolides, was being developed for use in livestock and penicillin, the tetracyclines, and bacitracin had recently been shown to promote the growth of pigs, poultry and calves.
While it is clear that the use of antimicrobial agents has broad and significant benefits, the appropriate use of these agents, including their selection, administration, monitoring and assessment, is a highly skilled discipline that incorporates all of the experience and expertise of veterinarians. Valuable sources of information that veterinarians rely on include textbooks and chapters on infectious diseases of multiple livestock species (47, 86, 97, 213, 244) , or specific species such as cattle (7, 10, 48, 283) , sheep and goats (3, 175) , pigs (33, 80, 177, 298) , and poultry (112, 142, 199, 225) .
Important subjects that will be addressed in this review include the patterns of antimicrobial use (prophylaxis, metaphylaxis, treatment and nutritional), the extent of use, fundamental elements of appropriate use and refinements to current use (including the role of physiologically based pharmacokinetic-pharmacodynamic modelling and population pharmacokinetics), diagnosis by point-of-care tests (POCTs), quality-assurance programmes, professional intervention by veterinarians and strengthening of measures to ensure the quality of veterinary medicines.
It should be recognised that there is no direct relationship between sales and doses administered. Older products such as the tetracyclines tend to be inexpensive and the cost per dose is likely to be significantly less than the cost of a dose of a more recently marketed quinolone or macrolide.
Global livestock production
The scale of antimicrobial use in livestock is related to the number of animals, the production system, prevailing risk factors for disease and ability to acquire antimicrobial agents.
Animal agriculture is the most widespread use of the world' s land surface. In many areas it is the only means of producing food from inedible vegetation. In almost all farming systems it is essential for converting inedible by-products and waste (12.4) ; Germany (12.0) ; Poland (8.1) ; Morocco (7.5) ; Portugal (6.8) The world' s livestock production systems (LPS) have been shaped by the requirements of linking demand with the availability of feed, water, labour and capital for livestock production. Production systems vary enormously in different regions and are the subject of ongoing and sometimes rapid and dramatic change. A widely used and valuable classification of LPS (239) applies criteria based on degree of integration with crops, land-use, climate zone, intensity of production and source of water to characterise the 11 systems described in Figure 1 . Table IV illustrates the relative global importance in livestock population and production of the four higherlevel LPS: landless LPS (LL), grassland-based LPS (LG), mixed rainfed LPS (MR) and mixed irrigated LPS (MI) (Fig. 1 ). It can be seen that landless systems that produce monogastric animals only (LLM) (otherwise known as intensive production units and often housing tens of thousands of animals in a single environment) are the major source of pig and poultry meat and eggs. Conversely, intensive production systems play only a minor role in global ruminant production (LLR). Most ruminant production takes place in mixed production systems that are rainfed or irrigated (MR or MI), although grazing systems producing ruminants are also important (LG). Similarly, most of the world' s milk supply is derived from mixed farming systems.
No systematic studies have been undertaken to explore the relationship between a particular LPS and the use of antimicrobial agents. However, risk factors for the major diseases of livestock are well known (see reference materials on infectious diseases described in the introduction) and the global trend towards intensification has the potential to increase the need for and costeffectiveness of antimicrobial use, especially in the early stages of intensification when biosecurity, vaccination and other important disease control measures are not as rigorously implemented. As noted recently (201) , veterinary medicines are used even in the most remote communities and are often administered by owners with little or no professional input, although the level of use is very low compared with that in intensive LPS.
Due to population growth, increasing urbanisation with increased demand for easily cooked nutritious food, and rising incomes that allow people to express their food preferences, the demand for livestock products, especially the products which smallholders can produce competitively, is the fastest growing market in the agricultural sector (254 
Fig. 1 Livestock production systems
Arid semiarid tropics and subtropics (MIA) worldwide human calorie consumption and 30% of protein consumption, while also contributing to crop production through the provision of transport and manure (249) . Livestock production and marketing can help stabilise the food supply, acting as a buffer to economic shocks and natural disasters for individuals and communities. However, the food supply from livestock can be destabilised, particularly by diseases (76) , and disease prevention and treatment is an important issue, especially when veterinary infrastructure is unavailable. Much of the future demand for livestock products, particularly from people living in urban areas, will have to be met by intensive medium-and large-scale production units with the potential to increase production per animal, per unit of land and per unit of time. The organisation of farming practice is fluid and dynamic as increasing productivity is sought. For example, in the USA significant increases in farm size between 1987 and 2007 have been associated with increased efficiency, productivity and economics (190) . The most notable change was the phenomenal 2,400% increase in the size of farms selling pigs. By 2007, as a result of significant changes in the pig sector, half of all pigs produced in the USA were produced on farms selling 30,000 pigs or more. Livestock production is also shifting geographically, first from rural areas to urban and periurban areas, to get closer to consumers, then towards the sources of feedstuffs. There is also a shift in species, with production of monogastric species (pigs and poultry, mostly produced in industrial units -LLM) growing rapidly, while the growth of ruminant production (cattle, sheep and goats, often raised extensively) slows (249) . Changes in rapidly growing developing countries are in stark contrast with trends in developed countries, where consumption of livestock products is growing only slowly or stagnating. The shifts in relative importance of the different LPS are likely to be associated with many unpredictable changes in the use of antimicrobial agents and provide an opportunity for strengthened Veterinary Services to deliver advice and guidance on appropriate use.
Infectious diseases of livestock
There are a large number of infectious diseases of livestock caused by a diversity of viral, bacterial, fungal, protozoal and metazoal pathogens. Indeed many diseases are polymicrobial, with several diseases resulting from a complex pathogenesis involving viral and bacterial agents (32, 193) . Antiviral and antifungal agents are rarely used in livestock. However, the impact of many important viral diseases is controlled by vaccination. This review is focused on antibacterial agents and Table V presents a summary of the most important bacterial pathogens of cattle, sheep, goats, pigs and poultry. Table V also includes a synopsis of the important protozoal agents (many of which are prevented or treated by agents with a spectrum of activity that includes protozoa as well as bacteria, e.g. the tetracyclines, sulphonamides and fluoroquinolones) and a list of the top five clinical syndromes in each species as reported by Member Countries of the World Organisation for Animal Health (OIE) (274) .
There are a multitude of pathogens each involved in one or more disease syndromes. Each pathogen has its own epidemiology, set of risk factors, pathogenic pathway and vulnerable host. Not every pathogen is present in every country or every region of each country. Veterinary clinicians should be familiar not only with the individual diseases of livestock but also with their differential diagnoses and the relative prevalence of each condition likely to be encountered in their area (213) . It is only with this knowledge that an initial therapeutic plan can be developed.
In 2000, the International Livestock Research Institute was commissioned to undertake a study to evaluate which diseases of livestock are most important to the poor in three major regions of the world (sub-Saharan Africa, South Asia and South-East Asia). The methodology included a series of consultative workshops with experts working at the front line of veterinary services (drawn from departments of Veterinary Services, non-governmental organisations, research institutions, universities, animal health service development projects and intergovernmental organisations) combined with literature reviews (203) . Table VI is based on information contained in this report and identifies the major diseases of livestock in Africa and Asia.
Many of the diseases included in the priority list in Table VI are amenable to prevention by vaccination (see  Table VIII ), but effective vaccination requires cold chain security to ensure vaccine quality and best practice vaccination, neither of which is readily available in Africa or Asia.
A comparison of Tables VI and VII shows that the priority pig diseases in Africa/Asia are quite different from the bacterial diseases affecting pig production in the USA. It is apparent that bacterial diseases are important in each of the four production categories of pig, but least so in breeding females. Preweaned pigs are affected most by navel and intestinal infections, nursery pigs by Streptococcal infection and colibacillosis and the older grower/finisher pigs are affected by respiratory disease and enteric Lawsonia infection. As is common with all species (including humans) there is an apparent age predisposition to certain disease syndromes. Interestingly, while neonatal mortality is common to pig production in the USA, Africa and Asia, the survey presented in Table VI did not identify as a priority any of the diseases encountered in pig production in the USA. Vaccine use is an essential part of disease management in intensive animal production and vaccines are also commonly used in extensive livestock production systems and can lead to dramatic improvements in animal health in village livestock (63, 150) . From an antimicrobial-use perspective, it should be appreciated that vaccine use can lead to significant reductions in the use of antimicrobial agents. For example, the use of the porcine reproductive and respiratory syndrome virus vaccine has been associated with a significant improvement in the health of pigs and a reduction in the use of antimicrobial agents (15) . Increased antimicrobial use is associated with the emergence of the immunosuppressive post-weaning multisystemic wasting syndrome in pigs (121) and vaccination to prevent emergence reduces concurrent bacterial disease and reduces the need to use antimicrobial agents. 
Antimicrobial agents

Critically important antimicrobials
The list of Critically Important Antimicrobials was developed as a reference to help formulate and prioritise risk assessment and risk management strategies for containing antimicrobial resistance due to non-human antimicrobial use (74) . A summary of the criteria underpinning the classification of medical (290) and veterinary antimicrobial agents (291) is presented in Table IX .
Antimicrobial use patterns
There are four major use patterns of antimicrobial agents in livestock, as described in Table X and illustrated in Figure 2 . It is important to note that these four patterns have been in use for many decades and were thoroughly described in the Swann Report in 1969 (255) . Figure 2 shows that prophylaxis, metaphylaxis and treatment are applied at different times during pathogen challenge. In intensive livestock operations (LLM and LLR) the objective is to minimise the occurrence of disease, and significant resources are generally applied to mitigate disease risk factors by ensuring each animal is as robust and resistant to pathogen challenge as possible. Risk mitigation is supported by careful selection of genotype, vaccination, biosecurity, nutrition, environmental controls and sound husbandry. Nevertheless, disease challenge is expected and early intervention is likely to reduce the impact as illustrated in Figure 2 .
Therapeutic use of antimicrobial agents
The value of prophylaxis in reducing pathogen challenge and disease and enhancing animal health and welfare has been demonstrated repeatedly for necrotic enteritis in broilers (31, 132, 286) and bovine respiratory disease (78, 98, 106, 165, 218, 236, 237, 238, 276, 278) . In addition, there is abundant evidence that metaphylaxis has significant benefits in reducing the impact of bovine (269, 270) respiratory disease (4, 180, 258) , lameness in ewes (229) , and diarrhoea in pre-weaned calves (143) . As diagnostic capacity improves, selective metaphylaxis is likely to become more common (88) , with reduced use of antimicrobial agents consistent with high animal health. There is growing evidence that another benefit of metaphylactic use of antimicrobial agents may be a reduced propensity to select for resistant bacteria. This is thought to be possible due to the lower bacterial inoculum present in the incipient stages of disease and the lower likelihood of resistant mutants being present in this smaller bacterial population (36, 129) . The dose regimen for prophylaxis, metaphylaxis and treatment can be based on knowledge of the expected minimum inhibitory concentration (MIC) of the pathogen expected to be implicated.
Nutritional use of antimicrobial agents
For the nutritional uses of antimicrobial agents (antibiotic growth promotion) it is not possible to select a dose regimen based on the MIC of any particular bacterial species as the specific mode (or modes) of action remains elusive. There are abundant theories to explain the mode of action (for example 59, 82, 123, 206) . More recent theories include non-antimicrobial anti-inflammatory effects on the gut (184), modulation of gut immune responses (49) or subtle changes in population composition of the gut microbiome (54, 219) .
Examples of use
The most commonly sold antimicrobial classes in the major livestock species in 17 countries are set out in Table XI .
The prominent use of the penicillins, tetracyclines, macrolides and aminoglycosides is notable, especially since each of these classes has been in use for more than 50 years. Although there are no specific findings recently from the USA for antimicrobial use in feedlot cattle, the major diseases that require management include bovine respiratory disease (which attracts the use of macrolides, tetracyclines, florfenicol and cephalosporins by injection) and liver abscess, which is prevented by the use of macrolides in feed (21) . In cow-calf herds in Canada, the main antimicrobials reported as used were oral and injectable sulphonamides and injectable tetracyclines, macrolides and penicillins in calves, and injectable tetracyclines and penicillins in cows (89) . In terms of used daily doses, a survey of 32 Belgian broiler farms showed that the main antimicrobial agents employed were macrolides, lincosamides, sulphonamide-trimethoprim and penicillins, with necrotic enteritis and the poorly -Short duration defined 'dysbacteriosis' the major reasons for use (204) . Similarly, in the United Kingdom (UK), a survey found that enteric disease, especially necrotic enteritis, and respiratory disease were the major indications for therapeutic use of antimicrobial agents (117) in broilers.
The use of antimicrobial agents in nursery and grower/finisher pigs in the USA is summarised in Table XII .
The primary use of injections was the treatment of respiratory disease in pigs and the primary use of in-feed antimicrobials was the prevention of this disease. The least popular route of administration was by water medication, which was mainly used for respiratory disease treatment. In Danish pig production in 2008 the antimicrobial agents most commonly used to treat enteric disease in nursery or weaner pigs were pleuromutilins, tetracyclines, macrolides and the combination of a sulphonamide and trimethoprim, for respiratory disease the most widely used antimicrobials were pleuromutilins, macrolides and tetracyclines. In finisher pigs, enteric disease was treated with tetracyclines, macrolides and pleuromutilins, while respiratory disease was treated with tetracyclines, pleuromutilins and penicillins (120) . In 2008 in Canadian grower-finisher pigs, the use of antimicrobial agents for enteric disease, respiratory disease and disease prevention was very similar to that described in the USA (55) .
The use of antimicrobial agents in dairy pre-weaned and weaned heifers and dairy cows is outlined in Table XIII .
While pre-weaned heifers were mainly treated for digestive and respiratory problems, weaned heifers were given infeed antimicrobial prophylaxis and dairy cows received intramammary antimicrobial agents for mastitis during lactation and at drying off.
Worldwide the treatment of mastitis is one of the most common reasons for administering antimicrobial agents to dairy cattle. 
Routes of administration
Antimicrobial agents may be administered directly to the site of infection by topical or intramammary routes or given by mouth (enteral administration) for local action in the gastrointestinal tract or for absorption and systemic action. They may also be administered parenterally, to bypass the gastrointestinal system, e.g. by intravenous, intramuscular (IM) or subcutaneous injection. Examples of the most common routes of administration in pigs and dairy cattle are presented in Tables XII and XIII .
Parenteral injection
Intramuscular
The intramuscular route of injection has traditionally been very popular in ruminants and pigs but can (depending on the irritancy of the active ingredient or its formulation) be associated with tissue damage (160, 187, 189, 294) , prolonged and high concentrations of residues (216) and, especially in pigs, broken needles. However, many antimicrobial agents can be formulated to be less tissue reactive and keeping injection volume per site to a maximum of 10 ml has been shown to be less likely to cause reactions (159) . It should be noted that the site of (188, 196) . To avoid high value muscles and ensure high bioavailability it is usually recommended that IM injections in cattle and pigs be made caudal to the base of the ear.
Subcutaneous
The subcutaneous route in cattle has now become the standard route of injection in many countries. Rapid and widespread adoption of subcutaneous injection followed the recognition that this method of administering antimicrobial agents was associated with pharmacokinetics that were not significantly different from those following intramuscular injection (17) and which resulted in minimal tissue irritation and limited economic losses associated with trimming at slaughter (277) . Preferred sites of subcutaneous injection in cattle are high in the neck, at the base of the ear or in the middle third of the posterior aspect of the ear.
Other sites
Less commonly, parenteral injections are given intravenously (usually ear vein or jugular vein) or intraperitoneally.
Enteral
Oral dosing of individual animals
When animal management permits, individual animals can be treated orally with a range of formulations, including tablets, capsules, boli (from simple to intrarumenal controlled release), suspensions, solutions or pastes. Young mammals can have medication added to milk or milk replacer, a common practice in calf-raising units.
Water medication
In the face of an emerging outbreak of disease, particularly in pigs and poultry, antimicrobial agents are frequently added to drinking water. In such situations this form of drug delivery is favoured as the water supply, especially of confined livestock, can be medicated immediately via header tanks or proportioning devices. Furthermore, it is believed that sick animals will continue to drink even though feed intake may be depressed. However, this belief may not be well founded as there is at least one study demonstrating that in pigs challenged with Actinobacillus pleuropneumoniae toxins there was a parallel reduction in feed and water intake (207) . When water medication is selected it is necessary to know average water consumption in order to determine the inclusion rate of the antimicrobial agent. Factors affecting water consumption of poultry (69, 172) , pigs (173) and beef cattle (174) include age and stage of growth, activity level, environmental temperature, humidity, water temperature, water quality (including hardness, mineral content, sulphate content), water palatability, feed composition and, particularly for poultry, lighting programme. In addition there may be variable wastage depending on the type and management of drinkers (140, 263) . Failure to ensure these factors are optimised can lead to ineffective drug delivery, as observed in a study of enrofloxacin in chickens (250, 251) . Because of the number of factors influencing water intake, it is usually recommended that current water intake is actually measured and used in calculations on dilution rates. In addition to an accurate estimate of water intake, it is essential to have a formulation of the antimicrobial agent that allows it to either dissolve or remain evenly suspended in the drinking water while maintaining its chemical stability. Medication may be delivered as a pulse (dose of medication added to water that will be consumed in a short period of time) or continuously throughout the period of treatment. In many cases pulse dosing may be more reliable, though the higher concentration of drug in the water may affect palatability leading to water rejection, as has been reported with florfenicol (100). In some cases, even high administration rates do not overcome inherently low bioavailability.
Tetracycline hydrochloride administered to pigs in water at concentrations of up to 500 mg/L led to mean steady-state plasma concentrations of less than 0.8 mg/L -inadequate for treatment of even highly susceptible bacteria (64, 157) . In another study, bioavailability of chlortetracycline administered in water was enhanced by the inclusion of citric acid (209) . A further important factor influencing the received dose of antimicrobial agent is the variation in the water flow rate in the animal facility. One recent study found that water flow rates varied between farms, between barns within farms and between pens within barns as well as according to type of drinker (64) .
Feed medication
Administration of antimicrobial agents in feed is one of the most widely adopted practices worldwide and a practice that should be undertaken in accordance with good animal feeding practices (46) . For small groups of animals, feed might be top dressed with the medication, but for larger groups the medication is usually incorporated into the final ration. The medicated feed may be offered as a dry loose mix, a mash, crumbles or pellets. The production of medicated feed must be undertaken by highly skilled workers to ensure the correct inclusion level (8), stability, homogeneity and lack of segregation of the active constituents (235). The carry-over of antimicrobial agents from batch to batch must be avoided to ensure that livestock are not unintentionally medicated, as this can have an impact on safety, residues and resistance selection.
To reduce the likelihood of carry-over at the mill, separate delivery systems should be used for higher risk compounds and special consideration paid to feed batch sequencing, flushing and the cleaning of feed processing equipment (107) . The physical form of antimicrobial premixes can influence carry-over, as has been demonstrated with sulphamethazine, which has a high propensity for electrostatic attraction when available as a powder but loses this property when granulated (222) . Delivery of feed also provides avenues for carry-over. The effective cleanout of feedlot mixer trucks involves sequences of feeds and flushing at various rates (up to 10% of mixer capacity) for various times (2 to 4 minutes) to reduce the likelihood of antimicrobial agent carry-over (279) . Once delivered and made available for livestock the constellation of factors that lead to feed intake variability come into operation (144) and consequent pharmacokinetic variability has been described by a feeding-behaviour model (139) .
Intramammary infusion
The anatomical construction of the mammary gland or udder of the ruminant (milk-producing cells draining into alveoli which themselves drain into the teat cistern which is connected to the exterior by a teat canal) (96) lends itself to intramammary administration of antimicrobial agents. Bacterial infection of the udder (mastitis) has always been one of the most costly infections of livestock (102, 108) and intramammary treatments were available prior to the modern age of antimicrobial agents, when acridine dyes were widely used (247) . It is essential to realise that there are two quite different types of intramammary preparation with distinct formulation characteristics -lactating and dry cow products -that are either quick acting (hours to days) or long acting (weeks to months) respectively.
Other routes of administration
For specific localised infections antimicrobial agents can be administered by intraarticular, intrapleural, intratracheal, ocular, subconjunctival, topical (for example, skin lesions, wounds), interdigital, intravaginal and intrauterine routes, and, in chickens, by the in ovo route.
Pharmacology
There regimens. Pharmacokinetics refers to those processes involved in characterising the concentration-time profile of a drug and includes absorption, distribution, metabolism and excretion. Pharmacodynamics refers to those processes that relate drug concentration to biological effect, and for antimicrobial drugs this includes the study of the various biochemical, physiological and microbiological factors that impact the growth, virulence and death of target microorganisms. Before exploring the value that these new approaches can add to optimal use of drugs, it is useful to consider how antimicrobials are used clinically.
Clinical approach to antimicrobial use
As summarised above and presented in greater detail elsewhere (see references), infectious disease of livestock is a complex phenomenon, each episode involving the epidemiological triad: host factors, infectious agents and environmental factors. The most serious disease events combine a large number of host factors for infection, a large number of potential infectious agents, and a diverse array of environmental factors. This makes correct diagnosis of pivotal importance. A flow chart of the clinical approach to antimicrobial use is set out in Figure 3 . Continuous review and reassessment of the diagnosis and response to treatment are fundamental features of each episode and each treatment event should be considered a unique experiment requiring professional management.
There is no fixed approach to the management of infectious disease and the use of antimicrobial agents. While it is likely that the majority of cases of infectious disease may have a successful outcome (because of or despite intervention), in other cases the response will not be as anticipated. The checklist set out in Box 2 provides examples of the factors that may help to elucidate why there was apparent treatment failure.
Amongst the causes of treatment failure are those affecting the interface of pharmacology and microbiology, at the site of infection, and include all the inter-and intra-animal sources of variability in pharmacokinetics and pharmacodynamics that lead to less than optimal tissue concentrations of the administered antimicrobial agent. In parallel with the situation with human antimicrobials (70), the dosage regimens on the labels of approved antimicrobial products for animals are usually based on the results of a small number of studies in homogeneous groups of animals. Furthermore, the microbiological characteristics of the pathogens infecting study animals in 
Population pharmacokinetics
Clinical response is affected not only by variability in rate and extent of free drug at the site of action but also variability in pharmacodynamic (PD) activity, which includes the host response to infection and bacterial susceptibility and growth kinetics. Population pharmacokinetics is a discipline designed to address the reality of significant biological and statistical variation in clinical response, as illustrated by the examples below. A PPK evaluation seeks to obtain pharmacokinetic (PK) information from individuals who are representative of the broad and heterogeneous population to which treatment is directed. Population pharmacokinetics recognises that sources of variability (for example, drug absorption, clearance, intersubject, intrasubject, interoccasion) are important and should be quantified and wherever possible investigated and evaluated (67) . As the following examples demonstrate, an understanding of PK and PD variability is essential for rational drug therapy (42) . Differences in antimicrobial disposition may be related to individual characteristics but also to subpopulation characteristics such as age, breed or physiological or pathological state (156) 
Variation
Two recent reviews of the influence of different physiological states on the pharmacokinetics of veterinary medicines included 54 publications that described aspects of the impact of age, infection, inflammation, lactation, pregnancy and hydration on the pharmacokinetic behaviour of antimicrobial agents in camels, cattle, pigs and sheep (153, 162) . It was concluded that the astute clinician must be alert to a significant number of variable pharmacokinetic factors that could influence the response to antimicrobial treatment and closely monitor each patient to ensure the desired outcome is attained. While interspecies PK differences are well known (18), a recent example of unpredictable, unexpected and fatal intraspecies variability highlights the importance of monitoring the response to treatment and investigating untoward outcomes. Fatal intoxication of pigs administered valnemulin was experienced in Denmark in 1999 and 2000. Adverse effects were confined to a small number of farms and to pigs from a specific breed, while pigs from other breeds tolerated elevated dose rates. Analysis of liver microsomes from pigs that were intoxicated revealed extremely low expression of those cytochrome P450 isoforms (CYP1A and CYP3A) involved in the metabolism of valnemulin, suggesting that the adverse effects were a result of genetic polymorphism of these CYPs (71) .
Inclusion of known important factors contributing to variability into PPK models allows the design of more individualised dose regimens for each subpopulation (42, 156) .
There are a slowly evolving number of reports of the application of PPK to inform antimicrobial use in livestock.
A PPK approach to evaluation of PK variability of doxycycline in sick pigs group fed with medicated feed (56) found large variation between pigs. The PPK of enrofloxacin and its active metabolite ciprofloxacin has been studied in disease-challenged chickens (99) and ill dairy cows (81) . The study in cattle revealed that PK variability was greatly influenced by daily milk production (DMP) and it was suggested that higher doses may be necessary in cows with higher DMP (in which case milk from these cows may not be fit for human consumption). In chickens, PK variability was quantified, and an assessment of the likelihood of achieving the PKPD target (AUC/MIC of 100 for Escherichia coli) determined. In this study, variation in MIC of the target pathogen (PD variability) was not assessed but could be readily included in a subsequent analysis.
Physiologically based pharmacokinetic models
Physiologically based pharmacokinetic models are based on compartments that reflect the anatomical and physiological structure of the body (133, 275) and an example of the structure of such a model is set out in Figure 4 . The model is constructed as a parallel series of organs interconnected by the arterial and venous arms of the circulatory system. The model can treat each tissue as if it is subdivided into vascular, extracellular and intracellular spaces. The drug permeability of each tissue can be set to reflect known physiological processes (for example, flow-limited or diffusion-limited, as may apply to the brain, the eye and other protected structures). Once the model structure is in place the next step is to apply appropriate species-specific physiological parameters such as organ mass or volume, and blood flow. Of course, the sum of all tissue blood flows must equal cardiac output. Values of these parameters are increasingly accessible in the literature and those for pigs and sheep have been published (272) . At this stage the model reflects a physiological species and is ready to interact with a drug delivered by any route. For illustrative purposes only, Figure 4 identifies oral, intramuscular, subcutaneous, intramammary and intravenous routes, however, other routes can be accommodated as required.
The final step in setting up the model is to add drug properties of the agent to be investigated. Important drug information includes physicochemical properties, including lipophilicity, protein binding, membrane permeability, tissue partitioning and hepatic metabolism, much of which can be derived from in vitro or in silico sources (176) .
The model can be made as complex or as simple as needed to address the questions it is being asked to explore. For example, if there was interest at looking at the PK behaviour of a drug administered directly by intramammary infusion, then the model could be made to focus simply on the mammary gland and possible routes of metabolism in the liver and kidney. Specific features can be added to meet specific situations, for example, complex gastrointestinal dissolution and absorption processes (29), enterohepatic drug circulation (296), protein binding (35) or drug release from a depot injection site (134) .
The interconnectedness of every part of the body is made abundantly clear in Figure 4 , which becomes an aidememoire when examining the distribution of antimicrobial agents. For example, in humans it has been found that following oral or parenteral administration of fluoroquinolones (113) and ␤-lactams (cephalosporins and penicillins) (114) microbiologically active concentrations were present in sweat. It was suggested that this may play an important part in the rapid selection of fluoroquinolone-resistant Staphylococcus epidermidis and ␤-lactam-resistant S. aureus. Antimicrobial agents are widely distributed in livestock species as well. Following intramuscular injection of pigs, enrofloxacin (26) and oxytetracyline (25) are present in nasal secretions at concentrations approximately the same as (enroflaxacin) or one third of (oxtetracycline) those in plasma. Fluoroquinolones are substrates for membrane transporters which are responsible for efflux into the gut (5) and into the ruminant mammary gland (210) . In either case, gut and mammary gland may be non-target sites and bacteria within each resident microbiome will be exposed to antimicrobial agents. Indeed, a study of enrofloxacin in pigs (288) found that intramuscular administration led to gut concentrations that were similar to those resulting from oral administration, and resistant Salmonella and E. coli were selected rapidly.
Tissue penetration (168, 170, 185, 234) to the site of action is essential for antimicrobial activity and is best assessed by microdialysis (125, 169) , which has significant advantages over other techniques, such as those using whole tissue homogenates or implanted tissue cages. Tissue and protein binding (19) essentially render antimicrobial agents unavailable, as it is the free fraction of the agent that is directly involved in antibacterial activity and it is the free fraction that is best measured by microdialysis.
Physiologically based pharmacokinetic models have been applied in an increasing number of veterinary contexts to -the disposition of chlortetracycline in turkeys (209) , valnemulin in pigs (296) , and doxycycline in pigs (295) -the kinetics of residue depletion of sulphamethazine in pigs (34) , antimicrobials in eggs (110) , and tulathromycin in goats (134) . Pharmacokinetic-pharmacodynamic models ' The overwhelming obscuring factor in divining the dose-concentration-effect relationship is variability in drug disposition and action' (115), thus a greater understanding of PK and PD and their sources of variability is paramount to improved antimicrobial use. Figure 5 illustrates the pathway that leads from selection of treatment and prescription of dose to effect or outcome.
There is first the pharmacokinetic phase, which relates delivered dose to a drug-concentration versus time profile, followed by the pharmacodynamic phase, which describes the biological effects associated with this changing concentration. There are a large number of sources of variability identified, to which other sources could be added.
Many studies have examined the relationship of PK and PD in determining the efficacy of antimicrobial agents (with excellent reviews: 6, 136, 137, 154, 195, 264, 265) .
Three PKPD indices have been proposed to allow predictions of antimicrobial efficacy (Fig. 6) . The ratio of the maximum unbound (free) concentration and the MIC (fCmax/MIC), the ratio of the free area under the concentration-time curve and the MIC (fAUC/MIC), and the percentage of time that the concentration of free drug is above the MIC (fT>MIC). The daily dose that has been demonstrated by dose-titration studies to provide acceptable antimicrobial activity can be fractionated and delivered as multiple divided doses. By doing this, it is possible, by assessing the response to each dose regimen, to determine whether or not the efficacy of the antimicrobial-bacterial species combination tested depends more on concentration (for example, single large dose leading to fCmax/MIC index of efficacy), or time (for example, frequent divided doses most effective, fT > MIC index of efficacy) or is responsive to all regimens (in which case fAUC/MIC may be correlated to efficacy). Such studies have suggested that macrolides, phenicols, tetracyclines, ␤-lactams, sulphonamides and potentiated sulphonamides are time dependent, and aminoglycosides and fluoroquinolones are concentration dependent (154) , but this classification itself is dependent on both the extent and duration of exposure of bacteria to each antimicrobial agent, and fAUC/MIC has been suggested as a universal predictor for all these classes (182).
The PKPD model approach has been applied to a number of dosing regimens in livestock, including the use of danofloxacin in calves (228, 240) and turkeys (104) , enrofloxacin in poultry (105, 214, 253) , oxytetracycline dose rates in sheep (246) , oxytetracycline residues in sheep (51), amoxicillin in sheep (57) , and colistin in pigs (101) . In several cases the PKPD model was able to demonstrate the benefits of changes in dosing regimens. For example, a study of oxytetracycline use in sheep in South Africa (246) revealed that increases in the MIC of a number of target pathogens meant that the antibacterial spectrum of current dose rates was reduced. In poultry, a modification of the approved dosage regimen of enrofloxacin in water (50 ppm continuously for five days) to a shorter, higher concentration regimen (125 ppm continuously for two days) showed potential for reduced resistance selection while maintaining efficacy (214) . Other studies in poultry support the advantages of a short, high-dose strategy with enrofloxacin (105, 253) .
One of the most clinically significant variables affecting the success of antimicrobial dose regimens is variability in the susceptibility and MIC of the target pathogens (147) . By assessing pathogen susceptibility it has been reported that it is possible to individualise dose regimens in everyday clinical practice (231) . However, the success of achieving the appropriate PKPD index by increasing the dose is very dependent on the shape of the dose-target attainment rate curve (154, 155) and it is likely that as MICs rise with resistance selection there will be little improvement in beneficial effect as dose is increased, though adverse effects may become more frequent.
Each of the commonly applied PKPD indices described in Figure 6 relies on the use of the MIC. However, use of the MIC has several disadvantages (182) which include:
-it is measured using serial twofold concentrations, which means the MIC is always less than the reported value -it is a threshold value, which suggests that there is either activity or there is not, when in reality there can be significant sub-and supra-MIC effects -it provides a summary measure of a complex set of antibacterial events happening throughout the incubation time -it is usually based on an inoculum size of 10 5-6 bacteria, which is considerably less than present in many infections -as an in vitro measure it does not account for the in vivo actions of leukocytes and a functioning immune system.
The other important criticism of the conventional PKPD indices is that each of the PK components (T, C max and AUC) are dependent covariates (73) and it has been suggested that it is pointless to search for the best predictive index if all are related.
Consequently, the future of PKPD indices may lie in those indices that can capture the full time-course of in vitro (or preferably in vivo) bacterial kill kinetics resulting from exposure to the change in concentration with time of the selected antimicrobial agent (52, 167, 171, 182, 257) .
In addition to the three conventional PKPD indices illustrated in Figure 6 , other indices based on the mutant prevention concentration (MPC) have been proposed in an attempt to preclude selection for resistance (27, 297) . The MPC is defined as the antibacterial concentration that inhibits the growth of the least-susceptible, singlestep mutant and is essentially the MIC of the least susceptible organism, often determined within an inoculum of 10 9-10 cfu/ml (36) . The concept was developed primarily for the fluoroquinolone class of antimicrobial agent as spontaneous point mutations are the principal resistance mechanism. A new PKPD index, fT>MPC/(time within the mutant-selection window), appeared to be predictive of resistance emergence in one study of marbofloxacin in a Klebsiella rat lung infection model (129) , however, it is not known if this new index can be generalised to other situations. Caution has been expressed about applying the MPC concept to ␤-lactams, macrolides or aminoglycosides or even to Gram-negative bacteria, as the primary modes of resistance involve horizontal gene transfer (HGT), inactivating enzymes or target-binding site changes (50, 58) rather than single step mutations.
While the MPC concept has encouraged the use of highdose regimens to reduce the likelihood of selection of resistant mutants, it appears that this approach may concurrently suppress the transfer of antimicrobial resistance plasmids, at least in in vitro studies (145) . However, while the MPC concept suggests that there is no selection for mutants at concentrations less than the MIC, this may not be the case, as hypermutation and HGT may be facilitated (36, 50, 149) .
The major challenge in developing PKPD indices to prevent resistance is the consequences of exposure of nontarget bacteria, particularly the commensal flora, which are inevitably exposed. As indicated above, there is already evidence of resistance selection in Salmonella via gut efflux of fluoroquinolones and Staphylococcus by ␤-lactam presence in sweat.
Combined population physiologically based pharmacokineticpharmacodynamic models
Physiologically based pharmacokinetic models that incorporate known distributions of physiological and anthropometric properties are already available for use in humans (287) and could readily be adapted for use in veterinary species. PK and PD variability in the animal population of interest can be evaluated by PBPK linked to PD models, the statistical distribution of the PK-PD index that is predictive of clinical efficacy can be established using Monte Carlo simulations and the probability of attaining the desired response (for example, PK-PD breakpoint) in a given proportion of the population can be determined by PPK.
Refinements in antimicrobial use
Measurement of antimicrobial use
A major impediment to any understanding or analysis of global antimicrobial use patterns is the absence of an internationally accepted standard approach to reporting antimicrobial usage (40, 79, 94, 122, 179, 248) . The human concept of the defined daily dose or DDD (defined as the assumed average maintenance dose per day for the drug used in its main indication and often expressed as DDDs/1,000 population/day) was first applied to the use of veterinary antimicrobial agents in 1999 (92) . This concept in a number of forms (for example, animal defined daily dose, prescribed daily dose and used daily dose) has been the basis of descriptions of the use of antimicrobials in pigs, poultry, and veal calves in Belgium (197, 204, 260) , dairy cattle in Switzerland (87) , poultry in Norway (93), dairy cattle in Wisconsin (208) , cow-calf operations in western Canada (89) , pigs in Denmark (120, 282) and turkeys and chickens in France (39, 41) . There is still no global consensus on which measure to use, although there is clearly a high level of importance to reach agreement on one or several indices.
Quality assurance programmes
To meet increasing consumer preferences for livestock products that are sourced from enterprises with high While each QA programme has its own objectives, common elements include (i) a philosophy of continuous improvement and (ii) ensuring all personnel are appropriately trained and are committed to safe and responsible use of all on-farm chemicals, including veterinary medicines such as antimicrobial agents. Records of medicine use are maintained and are among the documents subject to regular audit within the QA programme. In addition, most QA programmes require that each farm have plans for disease control and biosecurity.
Biosecurity plans
Biosecurity can be defined as 'the implementation of measures that reduce the risk of the introduction and spread of disease agents; it requires the adoption of a set of attitudes and behaviours by people to reduce risk in all activities involving domestic, captive/exotic and wild animals and their products' (77) . By providing a strong defence against the introduction of disease, biosecurity plans are associated with a reduction in the need for the use of antimicrobial agents. In addition to discussions of biosecurity in the textbooks recommended in the introduction of this paper, there are excellent descriptions of biosecurity for dairy farmers (241) , feedlot enterprises (227) , and cow-calf operations (226) . Manuals on biosecurity in poultry have been developed by a variety of organisations (12, 13, 44, 45) and the Food and Agriculture Organization of the United Nations has developed a manual on biosecurity in pigs (76) . One of the world' s major providers of broilers emphasised to its growers that '…prevention is by far the most economical and best method of disease control. Prevention is best achieved by the implementation of an effective biosecurity programme, including appropriate vaccination. Diseases do, however, overcome these precautions and when they do, it is important to obtain professional veterinary advice as quickly as possible' (44) .
Regulation
While a survey of OIE Member Countries in 2005 revealed that some countries have no regulations controlling the use of antimicrobial agents in livestock (274) the majority of the respondents noted that their countries do have laws and regulations governing the approval and use of veterinary medicines. However, as emphasised by participants in a World Health Organization (WHO) consultation on antimicrobial use in food animals (289) , and more recently by a study in India (224) , the implementation and enforcement of regulations is far from universally thorough. Even in developed countries such as the USA it is reported that many antimicrobial agents are readily available to livestock producers without a prescription (95) . This should not be surprising in view of the findings of a survey of human antimicrobial use (166) . In humans, nonprescription antimicrobial use occurred worldwide and accounted for between 19% and 100% of antimicrobial use outside of northern Europe and North America. It is unlikely that the animal health situation would be any better.
Professional veterinary support
The value of professional animal health intervention provided by veterinarians, paraveterinarians, community animal health workers and other trained health workers has been repeatedly emphasised (22, 75, 83, 152, 200, 242, 267) and most recently the results of a survey of OIE Member Countries reinforced the role of the veterinary sector as 'one of the guarantors of the stability and planned evolution of the world food system' (28). Yet even in developed countries there is no universal use of professional veterinary support. For example, a survey of pig producers in the USA (269) revealed that only 69% had used a veterinarian in the previous year. By contrast a separate survey of cattle feedlots found that veterinarians were used by 97% of operations and their recommendations had a strong or moderate influence on the selection of antimicrobial agents (268) . If such high veterinary input was normal it is likely that there would be significant improvements in disease prevention, diagnosis and antimicrobial use.
Bodyweight estimation and dose delivery
Overestimation and underestimation of bodyweight can lead to inaccurate antimicrobial dose delivery (197) . Visual estimation of the bodyweight of sheep by farmers has been found to be potentially inaccurate, with one study finding that only 27% of 273 farmers guessed bodyweights within 20% of the actual value (24) . Similarly, a study in Africa found that only 19% of cattle had their bodyweight estimated within 20% by cattle owners, although animal health workers were more accurate and the weight of 77% of cattle was estimated within 20% of the actual value (148) . The hipometer is an indirect tool that uses the external width between the greater trochanters of the left and right femurs to estimate the bodyweight of cattle, but in one study of Holstein heifers it was found to be accurate only in heifers between three and fifteen months of age (compared with electronic scales) (62) . Measurement of heart-girth (chest circumference) is commonly used to estimate the bodyweight of cattle, but this type of measurement (using weighbands) has been found to be less accurate than electronic scales, with overestimation averaging around 10% in one study (215) and greater errors being present in older rather than younger cattle in another study (194) . Both studies observed considerable differences in individual cattle. However, a recent study on weight estimation in Holstein heifers in the USA using a contemporary liveweight prediction equation found that weighbands can be accurate in particular circumstances, especially in Holstein heifers weighing more than 150 kg (109).
Evidence-based clinical decisions
The importance of using antimicrobial agents in a way which evidence suggests is least selective for resistance has been reinforced (158) . A recent review (280) reminded us that 'veterinarians involved in food production are required not only to identify what is the best therapeutic option for farm animals but also what is the most costeffective and economic approach'. Unfortunately there is a dearth of objective systematic reviews of the therapeutic literature. Even for globally important diseases, such as mastitis caused by S. aureus, there are few studies guiding veterinarians to the best antimicrobial treatment options (223) .
There are two notable and valuable examples of evidencebased decision support systems that rely on databases of relevant pharmacological and microbiological information. The 'Veterinary Antimicrobial Decision Support System' (www.vads.org) (11) regrettably remains a pilot demonstration programme awaiting renewed and ongoing support to keep it up to date and in line with new literature and developments. However, this innovative system clearly shows that it is possible to synthesise a huge dataset from diverse literature sources into a format that can be interrogated and provide information to underpin important clinical decisions. More recently, the 'One health evidence-based prudent use guidelines for antimicrobial treatment of pigs in Denmark' has been described (181), linking pharmacokinetic, pharmacodynamic and microbiological data. Pharmacology reviews and guidelines are currently available to support Danish veterinary decision-making (www.uk.foedevarestyrelsen. dk/forside. htm).
Just as informed veterinarians make better decisions, so too farmers and other end users (202) . For example, training farmers in rational drug use has been found to improve the management of infectious disease in cattle in Mali (90) .
Product quality
Veterinary medicine production in many countries must comply with demanding codes of good manufacturing practice (GMP). However, there are three main types of poor quality medicines (substandard, degraded and counterfeit) potentially available to end users (178) . Substandard products may be the result of poor and unregulated manufacturing practice. Degraded products are derived from those that were originally of high quality but have either exceeded their shelf life or have been stored inappropriately. Counterfeit (or fake) products are defined by WHO as products that are deliberately and fraudulently mislabelled with respect to identity and/or source (128) . Counterfeit products include drugs with the correct ingredients or with the wrong ingredients, without active ingredients, with insufficient active ingredient or with fake packaging. It has been estimated that up to 10% of the world's pharmaceutical trade, including 25% in developing countries, consists of fakes. It is unlikely that medicines available for animal health use are not as at risk of poor quality as those for human use. There are few cases published in the veterinary literature, although one report observed a preponderance of fake and/or expired drugs in Nigeria (61) and participants in a WHO consultation suggested that expired products were being relabelled and sold (289) . In countries where there is no regulatory requirement to demonstrate bioequivalence, some generic versions of pioneer products have been shown to be of variable quality and to have pharmacokinetic profiles unlikely to be associated with effective antimicrobial activity (250, 252) .
Improved diagnosis
Observation of livestock and diagnostic description by syndromic classification (for example, 'Dich Ta Heo' -epidemic diarrhoea of pigs [126] , 'Libuku' -blackquarter [151] , or watery excrements [204] ) is the usual first approach to diagnosis of adverse clinical presentations, whether observing pigs in Vietnam (126) , sheep in Canada (164) , small ruminants in southern Sudan (151) or broilers in Belgium (204) . Without further assessment (which often requires the availability of veterinary services) to establish the likelihood of involvement of pathogenic bacteria, such diagnostic categorisation can lead to overtreatment with antimicrobials and in some cases can delay the recognition of serious viral diseases (such as foot and mouth disease or classical swine fever) (126) .
The value of enhanced diagnostic capability has been repeatedly emphasised in both medical (60, 221, 266) and veterinary (65, 130, 202) contexts. It is very possible that the greatest improvement in antibacterial use will follow the introduction of POCTs. Targeted treatment guided by the results of such tests has already led to reduced use of antimicrobial agents in medical (198) and veterinary (130, 131) situations. The technology for such tests is improving rapidly (37, 135, 138, 183) , driven largely by the need for improvements in medical practice, especially in developing countries, but there should be many applications that can readily be transferred to animal health.
By adding the need to reduce resistance to the WHO criteria for an acceptable POCT, the necessary criteria can be described by the acronym ReASSURED: Resistancereducing, Affordable, Sensitive (low rate of false negatives), Specific (low rate of false positives), User-friendly (simple to perform in a few steps with minimal training), Robust and Rapid (results available in less than 30 min), Equipment-free, and Deliverable to those who need them (146, 191) . It is also vital that POCTs can distinguish colonisation from infection and this can be accomplished by detecting signals from pathogens as well as sensing the response of the host (205) .
The importance of accurate and early diagnosis of bovine respiratory disease (BRD) and the value of a chute-side test that improves detection has been emphasised (65) . Current methods for identifying cattle with BRD often rely on observation of clinical illness, which has been shown to have low sensitivity (62%) and low specificity (63%) (285) . By selecting only those calves with a rectal temperature of ≥39.7°C for targeted metaphylaxis it has been shown that the impact of BRD can be reduced. Moreover, this selective metaphylaxis uses fewer antimicrobial agents than mass medication and involves less handling of calves. (88) . Feeding behaviour may be predictive of impending illness (284) and it has been shown that electronic monitoring of the feeding behaviour of newly received feedlot calves permits earlier detection of morbidity than skilled pen-rider observation and earlier implementation of remedial measures, which usually results in a more successful outcome (212) . Measurement of the serum concentration of the acute phase inflammatory protein haptoglobin has been demonstrated to be useful in the early detection of metritis (118) , but is less predictive of BRD (116) in calves at feedlot arrival. The use of reticulo-rumen temperature boluses to identify visually undetected fever episodes in feedlot cattle (261, 262) is emerging as a possible approach to improving detection of BRD and other diseases associated with pyrexia.
It has been demonstrated that the earlier the detection and treatment of mastitis the higher the likelihood of bacterial elimination (111) , leading to the suggestion that an accurate cow-side test (a POCT) would be very valuable, but such tests are still far from ideal (127) . It has been reported that up to 40% of cultures from cases of clinical mastitis yield no bacterial growth and so do not require antimicrobial treatment. Use of the Minnesota Easy Culture System, a commercially available on-farm milk culture system for detection of gram-positive and gram-negative bacteria, has been shown to be a useful cow-side test that has the potential to reduce total antibiotic use on dairy farms by 25% (130, 131) . Similarly, if farmers can select cows at risk of mastitis and target them for selective dry cow treatment, further reductions in antimicrobial use may be possible (20, 211) .
In calf rearing units, diagnostic systems that flag inappetence and other early clinical signs of disease have been proposed as a way to allow targeted treatment of selected calves with diarrhoea (23) , avoiding the adverse consequences of antimicrobial-associated diarrhoea when non-discriminatory mass medication is employed.
High herd or flock health and reduced use of antimicrobial agents
Adoption of good farming practices as outlined by OIE (293) should ensure a high degree of health and welfare of livestock and reduce the need to treat clinical disease with antimicrobial agents. A sustained commitment to improved dairy herd health and reduced use of antimicrobials by Danish organic farmers has been described (273) . The most significant impediment to success was the presence of mastitis, but determined farmers were able to progressively reduce somatic cell counts in association with improved hygiene, outdoor access, use of nursing cows and drying off infected quarters with chronic mastitis.
A recent survey of antimicrobial use in poultry in Belgium found that 7 of 32 farms examined did not use antimicrobial agents in either of the production cycles monitored (204) . In New Zealand it has been reported that while bacitracin is commonly included in the feed for prevention of necrotic enteritis, the poultry meat industry notes that less than three in 100,000 flocks per year are given any class of therapeutic antimicrobial (161). A broiler company in Georgia (USA) commenced drug-free broiler production in 1999 with an objective of raising birds with no use of anticoccidial or antibacterial agents (245) . Although production costs are significantly higher than in conventional production systems, increased use of vaccines (especially those against coccidiosis, E. coli and necrotic enteritis), probiotics, prebiotics and other agents combined with enhanced biosecurity and careful breed selection has allowed the percentage of flocks requiring interventions with antimicrobial agents to control disease outbreaks to be reduced from 12% per annum to less than 1% in 12 years.
It would appear that under conditions where it is possible to maintain high standards of biosecurity, infection control (including vaccination), animal husbandry, nutrition, and environmental management, antimicrobial use can be more selective and targeted without adversely affecting the welfare or productivity of livestock.
Conclusion
There are myriad sources of pharmacokinetic and pharmacodynamic variation in response to the administration of antimicrobial agents by many different routes to a variety of species. The treatment of populations rather than individuals adds another dimension of complexity and source of variation. Furthermore, the existence of target pathogens with a range of susceptibilities to various antimicrobial agents that is in flux and changing with time and place further complicates the current use of such agents. The use of an antimicrobial agent should always be considered a trial. While there is an expected outcome, it is only by monitoring the response to administration that the expected response can be verified or an unexpected outcome can be identified and subjected to investigation. Each stage of the process of use (diagnosis, formulation of a therapeutic plan, selection of the most appropriate antimicrobial agent and administration and monitoring of response) requires the skilful application of detailed knowledge and experience. There are many ways in which existing uses of antimicrobial agents can be improved, amongst the most important are increased utilisation of veterinary professional services, the introduction of enhanced infection control measures, improved point-of-care diagnostic tests and the application of population PBPK-PD modelling. There is a need for a central resource that can provide undergraduate educational materials on antimicrobial use and, for continuing professional development, an ongoing objective assessment of the ever-expanding database that underpins decisions on appropriate antimicrobial use.
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Utilisation des agents antimicrobiens chez les animaux d'élevage
S.W. Page & P. Gautier
Résumé
Les agents antimicrobiens et notamment antibactériens sont utilisés partout dans le monde dans une grande diversité de systèmes de production animale, aussi bien extensifs qu'intensifs, dans le but de protéger la santé et le bien-être des animaux d'élevage et d'améliorer leurs performances. Si un petit nombre d'antimicrobiens utilisés en production animale appartiennent à des classes sans équivalent en médecine humaine, ce n'est pas le cas de la plupart des agents d'utilisation courante tels que les tétracyclines, les pénicillines, les macrolides et les sulfamides. La plupart des maladies bactériennes du bétail occasionnent des pertes considérables en termes d'effectifs et de productivité des élevages et grèvent dramatiquement les revenus et les moyens de subsistance des éleveurs, de sorte que la nécessité de traiter les animaux
Uso de agentes antimicrobianos en el ganado
S.W. Page & P. Gautier
Resumen En todo el mundo y en muy diversos sistemas de producción ganadera, tanto extensiva como intensiva, se utilizan agentes antimicrobianos, en especial antibacterianos, para proteger la salud y el bienestar del ganado y mejorar su rendimiento. Aunque algunos de los fármacos empleados en los animales pertenecen a clases que no tienen equivalente en medicina humana, no es el caso de los más extendidos: tetraciclinas, penicilinas, macrólidos y sulfonamidas. Muchas enfermedades bacterianas del ganado causan devastadoras pérdidas de vidas animales y productividad, además de diezmar dramáticamente los ingresos y medios de vida de los ganaderos. Por ello a menudo cunde la sensación de que urge tratar lo antes posible a los animales afectados. Sin embargo, hay un gran número de patógenos bacterianos que causan enfermedades, y muchas veces es difícil establecer un diagnóstico concluyente antes de poner en marcha el tratamiento. La forma en que actualmente se emplean los antimicrobianos es mejorable en muchos sentidos: entre las posibilidades más importantes están la de recurrir en mayor medida a los servicios de veterinarios profesionales, introducir medidas más eficaces de lucha antiinfecciosa, mejorar las pruebas de diagnóstico efectuadas en el lugar de tratamiento y aplicar modelos de farmacocinética-farmacodinámica de poblaciones basados en datos fisiológicos. 
Palabras clave
